XGN
NASDAQ
$4.68
Exagen Inc (XGN)
Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The company is headquartered in Vista, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $8.57 (+83.12%)
Market Cap
$104M
Free Cash Flow Yield
-13.64%
Beta (5Y)
1.40
Price Chart
Valuation
Market Cap$104M
P/S1.52
P/B6.84
Profitability
Total Revenue (TTM)$68M
Gross Profit (TTM)$40M
EBITDA-$12M
Profit Margin-22.9%
Operating Margin-19.7%
EPS-$0.89
Financial Health
Debt-to-Equity158.5%
Free Cash Flow Yield-13.64%
Growth & Risk
EPS 5Y CAGR-7.66%
Revenue 5Y CAGR+11.59%
FCF 5Y CAGR-3.40%
Beta (5Y)1.40
Sharpe Ratio-0.30